Document wr9a0yNVrzQ0bQ7QExNwwRwR4

From: Sent: To: Cc: Subject: Attach: Clegg, Patsy M SCC-CHSE-PC <patsy.c1egg@shell.com> Sunday, September 25,2005 10:59 PM (GMT) De Jong, Geert G SI-SHS <geert.dejong@shell.com> Tsai, Shan P SHLOIL-SHS <Shan.Tsai@shell.com>; Snyder, Phil J SCC-HSE-OE <phi1.snyder@shell.com>; Taalman, Rob DFM SI-SHS <Rob.Taalman@shell.com>; Cagen, Stuart Z SCC-CF-SS <stuart.cagen@shell.com> RE: Shanghai studies Shanghai Health Study - Mehlman Letterpdf.ZIP; Princeton letter_050630.ZIP Geert, Thanks for sending this. Yes, many top executives of the Shanghai sponsors got a letter from Mehlman and we chose to respond. See attached Mehlman letter and our response. We recognized early that there potentially would be negative responses. I will forward this to the other sponsors and keep you in the loop of what we do. The 2-gen repro is of interest especially to the children's health (VCCEP) program in the US. ~garcfs) Patsy Patsy Clegg Product Steward, HSSE Shell Chemical LP One Shell Plaza, 910 Louisiana, Houston, TX 77002-4916 Tel: +1 713241 2521 Fax: 3325 Email: patsy.clegg@shell.com Internet: http://www.shell.com/chemicals (]3usiness Success tlirougli JfSSE ~effence -----Original Message----From: De Jong, Geert G SI-SHS Sent: Friday, September 23,20059:35 AM To: Clegg, Patsy M SCC-CHSE-PC Cc: Tsai, Shan P SHLOIL-SHS; Snyder, Phil J SCC-HSE-OE; Taalman, Rob DFM SI-SHS Subject: FW: Shanghai studies Patsy Did you know this? I will obtain additional information. Regards, Geert -----Original Message----From: Urbanus Jan [mailto:jan.urbanus@concawe.org] SH ELL-MCCLU RG-OS4773 Sent: Thursday, September 22,20055:48 PM To: Bruce Jarnot; twerdokl@api.org Cc: rileyaj@uk.bp.com; chris.money@exxonmobil.com; De Jong, Geert G SI-SHS; a.r.schnatter@exxonmobil.com Subject: Shanghai studies I had the questionable pleasure of attending the Collegium Ramazzini meeting earlier this week in Italy. I will write up a note with the most noticeable communications of the meeting (including the findings of a 2-generation carcinogenicity rat study with Coca-Cola - ad libitum). There were some quite negative remarks from some of the leaders of the meeting about the ongoing benzene work in Shanghai: only purpose is to discredit the NCI findings (Bingham) industry-sponsored studies equate to junk science (slide put up by Mehlman) ridicule by Mehlman about single response (P Clegg, Shell) to a letter to 45 oil executives I'm sure you were already aware of this what looks like a coordinated campaign. If not, you're now. Jan Urbanus Technical Coordinator, Health Issues CONCAWE (the oil companies' european organisation for environment, health and safety) Boulevard du Souverain, 165 B-1160 Brussels, Belgium T: +32-2-566 9163 F: +32-2-566 9181 E: jan.urbanus@concawe.org www.concawe.org SH ELL-MCCLU RG-OS4774